The therapeutic use of cholinergic drugs acting on the vegetative nervous system. I - Direct, indirect and mixed agonists.
D000818:Animals; D001115:Arecoline / Q000627:therapeutic use; D001626:Bethanechol Compounds / Q000627:therapeutic use; D002217:Carbachol / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D004246:Dimethylphenylpiperazinium Iodide / Q000031:analogs & derivatives / Q000627:therapeutic use; D005724:Ganglia / Q000187:drug effects; D007700:Kinetics; D008120:Lobeline / Q000627:therapeutic use; D009451:Neuroeffector Junction / Q000187:drug effects; D009538:Nicotine / Q000627:therapeutic use; D010095:Oxotremorine / Q000627:therapeutic use; D010277:Parasympathomimetics / Q000627:therapeutic use*; D010862:Pilocarpine / Q000627:therapeutic use; D013237:Stereoisomerism
D001626:Bethanechol Compounds; D010277:Parasympathomimetics; D010862:Pilocarpine; D001115:Arecoline; D004246:Dimethylphenylpiperazinium Iodide; D010095:Oxotremorine; D009538:Nicotine; D002217:Carbachol; D008120:Lobeline